related documents
- A meta-analysis of hip protector trials in institutionalized elderly using a Bayesian approach. Conference Paper
- Barriers and facilitators to osteoporosis medication adherence: Patient perceptions and strategies. Conference Paper
- Family physicians' awareness of key osteoporosis risk factors and the utilization of bone mineral density (BMD) testing following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project. Conference Paper
- Knowledge dissemination strategies translate into improved post-fracture osteoporosis care Conference Paper
- Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre osteoporosis study (CaMOS). Conference Paper
- Risedronate demonstrates antifracture efficacy over a range of baseline BMD levels. Conference Paper
- The economic implications of a policy of provision of hip protectors to institutionalized elderly in Ontario, Canada. Conference Paper
- The evaluation of process factors involved in performing the Canadian Quality Circle (CQC) Pilot Project for the care of patients at risk for osteoporosis. Conference Paper
- The rate that family physicians prescribe osteoporosis medications to their patients: Canadian Quality Circles (CQC) Project. Conference Paper
- Treatment-related changes in BMD are not associated with the occurrence of a fragility fracture while on risedronate therapy Conference Paper